ATE192163T1 - Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus - Google Patents

Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus

Info

Publication number
ATE192163T1
ATE192163T1 AT93917473T AT93917473T ATE192163T1 AT E192163 T1 ATE192163 T1 AT E192163T1 AT 93917473 T AT93917473 T AT 93917473T AT 93917473 T AT93917473 T AT 93917473T AT E192163 T1 ATE192163 T1 AT E192163T1
Authority
AT
Austria
Prior art keywords
analogues
peptides
proteins
mixtures
generation
Prior art date
Application number
AT93917473T
Other languages
English (en)
Inventor
Maan Zrein
Martial Lacroix
Original Assignee
Biochem Immunosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Immunosystems Inc filed Critical Biochem Immunosystems Inc
Application granted granted Critical
Publication of ATE192163T1 publication Critical patent/ATE192163T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93917473T 1992-08-07 1993-07-30 Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus ATE192163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/927,071 US5427792A (en) 1989-08-23 1992-08-07 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
PCT/CA1993/000306 WO1994003490A1 (en) 1992-08-07 1993-07-30 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus

Publications (1)

Publication Number Publication Date
ATE192163T1 true ATE192163T1 (de) 2000-05-15

Family

ID=25454125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917473T ATE192163T1 (de) 1992-08-07 1993-07-30 Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus

Country Status (13)

Country Link
US (1) US5427792A (de)
EP (1) EP0656013B1 (de)
JP (1) JP3492686B2 (de)
AP (1) AP453A (de)
AT (1) ATE192163T1 (de)
AU (1) AU690070B2 (de)
CA (1) CA2141670C (de)
DE (1) DE69328488T2 (de)
ES (1) ES2145055T3 (de)
IL (1) IL106592A (de)
PT (1) PT656013E (de)
WO (1) WO1994003490A1 (de)
ZA (1) ZA935642B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238660A1 (en) * 1998-05-22 1999-11-22 Janet Chantler Gene sequences of rubella virus associated with attenuation
WO2000033081A1 (en) * 1998-12-01 2000-06-08 Viral Antigens, Inc. IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
BR102018075339A2 (pt) * 2018-12-06 2021-11-16 Fundação Oswaldo Cruz Proteína recombinante, sequência de dna sintético, vetor de expressão, célula hospedeira, composição, kit para diagnóstico de rubéola, uso de pelo menos uma proteína recombinante, e, métodos para produzir uma proteína recombinante e para diagnóstico de rubéola
CN110423272A (zh) * 2019-08-15 2019-11-08 捷敏(天津)生物技术有限公司 一种新的抗风疹病毒膜蛋白e1的抗体及其应用技术领域

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
EP0299673A1 (de) * 1987-07-08 1989-01-18 London Biotechnology Limited E1-Glykoproteinantigene von Rubella
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine

Also Published As

Publication number Publication date
JP3492686B2 (ja) 2004-02-03
PT656013E (pt) 2000-10-31
EP0656013B1 (de) 2000-04-26
AU4693493A (en) 1994-03-03
US5427792A (en) 1995-06-27
AP453A (en) 1996-01-20
ZA935642B (en) 1995-02-06
CA2141670A1 (en) 1994-02-17
JPH08502724A (ja) 1996-03-26
IL106592A (en) 2001-01-11
AP9300556A0 (en) 1993-10-31
DE69328488D1 (de) 2000-05-31
ES2145055T3 (es) 2000-07-01
DE69328488T2 (de) 2000-11-30
CA2141670C (en) 2007-03-06
EP0656013A1 (de) 1995-06-07
IL106592A0 (en) 1993-12-08
WO1994003490A1 (en) 1994-02-17
AU690070B2 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
DE3787002D1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
DK0862633T3 (da) VP-antigen af JC-virus
DE69535018D1 (de) Papillomavirus vakzine
DE69029092D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
DE68903576D1 (de) Signalpeptide, die in hefe wirksam sind und ihre verwendung zur sekretorischen expression von heterologen proteinen.
KR970702919A (ko) 재조합형의 인간면역부전바이러스 담체 및 그 제조방법(Recombinant Human Immunodeficiency Virus Vector and Process for Producing the same)
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
DE59505585D1 (de) Antigene und Antikörper zum Nachweis von Kollagen I
EP0747482A3 (de) Rekombinante Proteine des Hepatitis GB Virus ihre Verwendungen
ATE124419T1 (de) Peptide und analoge und mischungen davon zum nachweis der gegen die viren htlv-1 und htlv-ii gerichteten antikörper.
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
DE69011122D1 (de) Rubella-e1 und c peptide.
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE69428610D1 (de) Methoden zur kultivierung von infektiösem laryngotracheitis virus und von "egg-drop-syndrome" verursachendem virus
FI952779A7 (fi) HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
ATE92934T1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
ATE62019T1 (de) Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee